前DeepMind研究人员为AI科学初创公司Inherent筹集5000万美元
Ex-DeepMind researchers raise $50m for AI science startup Inherent
摘要
前DeepMind研究员创立的AI科学初创公司Inherent完成5000万美元融资。该公司致力于利用人工智能技术加速科学发现，凸显了AI for Science领域的商业吸引力。
前DeepMind研究员创立的AI科学初创公司Inherent完成5000万美元融资。该公司致力于利用人工智能技术加速科学发现，凸显了AI for Science领域的商业吸引力。
该文章仅爬取到标题，未获取到正文内容。
查看原文
Summary
Former DeepMind researchers have raised $50 million for their new startup, Inherent, which focuses on applying AI to scientific research. The company aims to accelerate discovery in fields like biology and chemistry, signaling growing investor confidence in AI-driven science.
Former DeepMind researchers have raised $50 million for their new startup, Inherent, which focuses on applying AI to scientific research. The company aims to accelerate discovery in fields like biology and chemistry, signaling growing investor confidence in AI-driven science.
Only the headline was crawled; full content was not available.
Read original
Résumé
D'anciens chercheurs de DeepMind ont levé 50 millions de dollars pour financer Inherent, une startup appliquant l'IA à la recherche scientifique. Cette levée de fonds, menée par des investisseurs non divulgués, vise à accélérer les découvertes grâce à des modèles d'IA avancés.
D'anciens chercheurs de DeepMind ont levé 50 millions de dollars pour financer Inherent, une startup appliquant l'IA à la recherche scientifique. Cette levée de fonds, menée par des investisseurs non divulgués, vise à accélérer les découvertes grâce à des modèles d'IA avancés.
Seul le titre a été récupéré.
Lire l'originalCore Point
Ex-DeepMind researchers secured $50M for AI science startup Inherent, highlighting strong investor appetite for foundational AI models that accelerate scientific discovery.
Key Players
- Inherent — AI startup applying machine learning to scientific research, founded by former DeepMind staff; location not disclosed.
- DeepMind — Alphabet-owned AI research lab renowned for AlphaFold, based in London.
Industry Impact
- Computing/AI: High — signals sustained capital flow into specialized AI, pushing beyond general-purpose models.
- Healthcare: Medium — likely targets drug discovery and biological breakthroughs, amplifying existing AI-driven R&D trends.
Tracking
Strongly track — AI-native science startups could disrupt high-value R&D in pharma and materials; monitor Inherent’s focus area and technical milestones closely.